Both in Pharmaceuticals
Stoke Therapeutics vs Zenas BioPharma
Over the past year STOK returned −20.4% and ZBIO returned −9.2%; their daily moves had a correlation of 0.12.
STOK −20.4% ZBIO −9.2%Growth of $1, one year, split-adjusted
| Metric | STOK | ZBIO |
|---|---|---|
| Price | $26.28 | $28.86 |
| Market cap | $1.70B | $1.88B |
| Today | +0.57% | +5.71% |
| 1 month | +1.5% | +7.8% |
| 6 months | −18.9% | +64.4% |
| Year to date | −17.2% | −20.5% |
| 1 year | −20.4% | −9.2% |
| Revenue growth (YoY) | −32.5% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −660.8% | −11145.6% |
| P/E (TTM) | — | — |
| Price / sales | 61.5× | 1,881.0× |
| Net cash | $292.8M | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | 48.1% | 55.7% |
| Short % of float | 18.9% | 40.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).